SOON-SHIONG PATRICK — SEC Form 4 filings
SEC reporting owner CIK 1189020. 9 Form 4 filings on record with FilingPulse; latest filed 2026-04-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-20 to 2026-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 442,298 shares, $672,072 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: purchase of 442,298 shares @ $1.52 ($672,072) in Heliogen, Inc., filed 2024-02-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Heliogen, Inc. (HLGN) | 10% owner | 1 | 1 leg · 442,298 sh · $672,072 | — | — |
| ImmunityBio, Inc. (IBRX) | See remarks, Director, 10% owner | 7 | — | — | 21 |
| Panbela Therapeutics, Inc. (PBLA) | 10% owner | 1 | — | — | 1 |
Form 4 filings — SOON-SHIONG PATRICK
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-02 | 4 | ImmunityBio, Inc. (IBRX) jointly with CALIFORNIA CAPITAL EQUITY, LLC, Cambridge Equities, LP, MP 13 Ventures, LLC, Nant Capital, LLC | Conversion (C): 4,606,596 @ $5.43 · Conversion (C) @ $0 | EDGAR |
| 2026-02-24 | 4 | ImmunityBio, Inc. (IBRX) jointly with CALIFORNIA CAPITAL EQUITY, LLC, Cambridge Equities, LP, MP 13 Ventures, LLC, Nant Capital, LLC | Option exercise (M): 114,329 @ $0 · Tax withholding (F): 58,170 @ $8.70 · Option exercise (M): 114,329 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | ImmunityBio, Inc. (IBRX) jointly with CALIFORNIA CAPITAL EQUITY, LLC, Cambridge Equities, LP, MP 13 Ventures, LLC, Nant Capital, LLC | Option exercise (M): 274,122 @ $0 · Tax withholding (F): 118,560 @ $6.93 · Option exercise (M): 274,122 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | ImmunityBio, Inc. (IBRX) jointly with CALIFORNIA CAPITAL EQUITY, LLC, MP 13 Ventures, LLC, Cambridge Equities, LP, Nant Capital, LLC | Option exercise (M): 114,329 @ $0 · Tax withholding (F): 42,071 @ $3.42 · Option exercise (M): 114,329 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 822,368 (derivative) @ $0 · Grant/award (A): 2,812,500 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | ImmunityBio, Inc. (IBRX) jointly with CALIFORNIA CAPITAL EQUITY, LLC, MP 13 Ventures, LLC, Cambridge Equities, LP, Nant Capital, LLC | Conversion (C): 103,710,088 @ $1.94 · Conversion (C): 13,475,172 @ $2.28 · Conversion (C) @ $0 · Conversion (C) @ $0 · Other (J) @ $0 · Other (J) @ $505,000,000 | EDGAR |
| 2024-11-19 | 4 | Panbela Therapeutics, Inc. (PBLA) jointly with Nant Capital, LLC | Purchase (P) @ $9,150,000 | EDGAR |
| 2024-02-26 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 342,987 (derivative) @ $0 · Grant/award (A): 1,193,597 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Heliogen, Inc. (HLGN) jointly with Nant Capital, LLC, Cambridge Equities, LP, MP 13 Ventures, LLC | Purchase (P): 442,298 @ $1.52 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1189020 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →